Funds and ETFs Viking Therapeutics, Inc.
Equities
VKTX
US92686J1060
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
62.75 USD | +1.92% | -6.34% | +237.18% |
May. 17 | Raymond James Upgrades Viking Therapeutics to Strong Buy From Outperform | MT |
May. 17 | North American Morning Briefing : The "Everything -2- | DJ |
ETFs positioned on Viking Therapeutics, Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.13% | 2 M€ | -.--% | ||
0.06% | 7 M€ | -.--% | - | |
0.00% | 34 M€ | +4.20% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+237.18% | 6.92B | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- VKTX Stock
- Funds and ETFs Viking Therapeutics, Inc.